Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: Long-term follow-up of the Northwestern University experience

Blood

Volumn 88, Issue 6, 1996, Pages 1954-1959

  Tallman, Martin S ^a   Hakimian, David ^b   Rademaker, Alfred W ^b   Zanzig, Connie ^b   Wollins, Eric ^b   Rose, Esther ^b   Peterson, LoAnn C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SPLENECTOMY; TREATMENT OUTCOME;

EID: 0029795202     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.1954.bloodjournal8861954     Document Type: Article

References (25)

1. Golomb HM, Catovsky D, Golde DW: Hairy cell leukemia: A clinical review based on 71 cases. Ann Intern Med 89:677, 1978
2. Piro LD, Carrera CJ, Carson DA, Beutler E: Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322:1117, 1990
3. Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh Yo, Stass S, Freireich EJ: Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79:882, 1992
4. Juliusson G, Liliemark J: Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): Relation to opportunistic infections. Blood 79:888, 1992
5. Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, Rose E, Kaul K: A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80:2203, 1992
6. Hakimian D, Tallman MS, Kiley C, Peterson L: Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82:179, 1993
7. Ellison DJ, Sharpe RW, Spinosa JG, Robbins BA, Eito WR, Lukes RJ, Saven A, Piro LD: Immunomorphologic evaluation of post-therapy bone marrows in patients treated with 2-CdA for HCL. Blood 84:4310, 1994
8. Filleul B, Delannoy A, Ferrant A, Zenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, Sokal G, Martiat P, Michaux JL: A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 8:1153, 1994
9. Carbone A, Reato G, DiCelle F, Lauria F, Foa R: Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia 8:2019, 1994 (letter)
10. Cools L, Osteaux M, Divano L, Jeanmart L: Prediction of splenic volume by simple CT measurement: A statistical study. J Comput Assist Tomogr 7:426, 1983
11. Golomb HM, Vardiman JW: Response to splenectomy in 65 patients with hairy cell leukemia: An evaluation of spleen weight and bone marrow involvement. Blood 61:349, 1983
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
13. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649, 1982
14. Hakimian D, Tallman M, Rademaker AW, Nemcek A: Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. J Clin Oncol 12:268, 1994
15. + lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906, 1994
16. Piro LD, Ellison DJ, Saven A: The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia. Leuk Lymph 13:121, 1994 (suppl 1)
17. Kraut EH, Grever MR, Bouroncle BA: Long-term follow-up of patients with hairy cell leukemia after treatment with 2-deoxycoformycin. Blood 84:4061, 1994
18. Golomb HM, Dodge R, Mick R, Budman D, Hutchison R, Horning SJ, Schiffer CA: Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: A report of CALGB Study 8515. Leukemia 8:2037, 1994
19. Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchinson RE, Corbett WEN, Cassileth PA, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson BD: A randomized comparison of pentostatin vs alpha-interferon in previously untreated patients with hairy cell leukemia: An intergroup study. J Clin Oncol 13:974, 1995
20. Catovsky D, Matutes E, Talavera JG, O'Connor NT, Johnson SA, Emmett E, Corbett L, Swansbury J: Long-term results with 2′deoxycoformycin in hairy cell leukemia. Leuk Lymph 14:109, 1994 (suppl 1)
21. Wheaton S, Tallman MS, Hakimian D, Peterson L: Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia with 2-chlorodeoxyadenosine. Blood 87:1556, 1996
22. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman JW: Increased incidence of second neoplasms in patients treated with Interferon alpha 2b for hairy cell leukemia: A clinicopathologic assessment. Blood 83:2931, 1994
23. Lauria F, Benfenati D, Raspadori D, Rondelli D, Ventura MA, Pileri S, Sabattini E, Poggi S, Benni M, Tura S: Retreatment with 2-CdA of progressed HCL patients. Leuk Lymph 14:143, 1994 (suppl 1)
24. Saven A, Piro LD: Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2-deoxycoformycin. Ann Intern Med 119:278, 1993
25. Seymour JF, Estey EH, Keating MJ, Kurzrock R: Response to interferon-α in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia 9:929, 1995